<div id="readability-page-1"><p><span>Strategy (NASDAQ:MSTR - Get Free Report)</span> had its price target decreased by research analysts at TD Cowen  from $640.00 to $620.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a &#34;buy&#34; rating on the software maker's stock. TD Cowen's price target would indicate a potential upside of 89.78% from the stock's previous close.</p><ul><li>MarketBeat Week in Review – 09/08 - 09/12</li></ul><p>Other research analysts have also issued research reports about the stock. BTIG Research raised their price objective on shares of Strategy from $620.00 to $700.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, August 1st. Mizuho raised their price objective on shares of Strategy from $563.00 to $586.00 and gave the company an &#34;outperform&#34; rating in a research note on Monday, August 11th. Cantor Fitzgerald  reissued an &#34;overweight&#34; rating on shares of Strategy in a research note on Wednesday, August 13th. Barclays  reissued a &#34;hold&#34; rating on shares of Strategy in a research note on Monday, May 19th. Finally, Benchmark  reissued a &#34;buy&#34; rating on shares of Strategy in a research note on Wednesday, August 13th. One research analyst  has rated the stock with a Strong Buy rating, eleven have assigned  a Buy rating, one  has issued  a Hold rating and one  has issued  a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $547.50.</p><p><b>Read Our Latest Research Report on Strategy</b></p><h2>Strategy Trading Down 0.3%</h2><ul><li>Take the Money and Run: Strategy Stock Looks Tapped Out</li></ul><p>MSTR stock traded down $1.09 during mid-day trading on Tuesday, hitting $326.70. 1,712,975 shares of the company were exchanged, compared to its average volume of 14,826,387. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $92.64 billion, a P/E ratio of 28.79 and a beta of 3.82. The business has a fifty day simple moving average of $377.99 and a 200-day simple moving average of $358.03. Strategy has a 12-month low of $128.51 and a 12-month high of $543.00. </p><p>Strategy (NASDAQ:MSTR - Get Free Report) last announced its earnings results on Thursday, July 31st. The software maker reported $32.60 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $32.72. The company had revenue of $114.49 million during the quarter, compared to analyst estimates of $112.68 million. Strategy had a net margin of 1,036.61% and a return on equity of 18.83%. Strategy's revenue was up 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted ($5.74) earnings per share.  Strategy has set its FY 2025 guidance at 80.000-80.000 EPS.</p><h2>Insider Activity at Strategy</h2><ul><li>Time to Take Profits on Strategy Stock? 3 Reasons You Should</li></ul><p>In other Strategy news, CFO Andrew Kang sold 18,750 shares of the firm's stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $395.00, for a total transaction of $7,406,250.00. Following the sale, the chief financial officer owned 24,460 shares of the company's stock, valued at approximately $9,661,700. This trade represents a 43.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Also, Director Gregg Winiarski bought 10,000 shares of the business's stock in a transaction dated Friday, August 8th. The stock was acquired at an average cost of $97.65 per share, for a total transaction of $976,500.00. Following the completion of the acquisition, the director directly owned 10,000 shares in the company, valued at approximately $976,500. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 252,974 shares of company stock valued at $22,844,759 and have sold 142,150 shares valued at $59,289,351. Company insiders own  8.46% of the company's stock. </p><h2>Hedge Funds Weigh In On Strategy</h2><p>Institutional investors have recently modified their holdings of the business. First United Bank &amp; Trust acquired a new position in shares of  Strategy in the 1st quarter valued at $29,000.  Siemens Fonds Invest GmbH increased its holdings in shares of  Strategy by 6,992.7% in the 4th quarter. Siemens Fonds Invest GmbH now owns 119,654 shares of the software maker's stock valued at $33,000 after acquiring an additional 117,967 shares during the period.  Binnacle Investments Inc increased its holdings in shares of  Strategy by 492.9% in the 2nd quarter. Binnacle Investments Inc now owns 83 shares of the software maker's stock valued at $34,000 after acquiring an additional 69 shares during the period.  MCF Advisors LLC acquired a new position in shares of  Strategy in the 2nd quarter valued at $35,000.  Finally, Maseco LLP acquired a new position in shares of  Strategy in the 2nd quarter valued at $36,000. 59.84% of the stock is owned by institutional investors and hedge funds. </p><h2>About Strategy</h2> (Get Free Report)<p>Strategy Incorporated, formerly known as MicroStrategy, provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers Strategy ONE, a platform that allows non-technical users to access novel and actionable insights for decision-making, and Strategy Cloud for Government, which provides always-on threat monitoring designed to meet the strict technical and regulatory standards of governments and financial institutions.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Strategy</li><li>What Are Some of the Best Large-Cap Stocks to Buy?</li><li>3 Under-the-Radar Stocks Set to Benefit From Oracle’s Boom</li><li>Stock Market Sectors: What Are They and How Many Are There? </li><li>Lululemon’s Sell-Off Looks Overdone: A Contrarian Case</li><li>The Significance of Brokerage Rankings in Stock Selection</li><li>How Bath &amp; Body Works Is a Perfect Example of a Value Stock </li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TVNUUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TVNUUg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Strategy Right Now?</h2><p>Before you consider Strategy, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Strategy wasn't on the list.</p><p>While Strategy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MSTR

SMST

MSTZ

07799

07399

<p>TD Cowen has lowered its price target for Strategy (NASDAQ:MSTR) from $640.00 to $620.00 while maintaining a "buy" rating. This new target suggests a potential upside of 89.78% from the stock's previous close. Other analysts have varied opinions, with BTIG Research raising their target to $700.00 and Mizuho to $586.00. The stock is currently trading at $326.70, down 0.3%. Strategy reported strong earnings, exceeding estimates, and has a market cap of $92.64 billion.</p>

Market Beat

Strategy

Defiance Daily Target 2X Short MSTR ETF

T-REX 2X Inverse MSTR Daily Target ETF

XL2CSOPMSTR

XI2CSOPMSTR

TD Cowen Lowers Strategy (NASDAQ:MSTR) Price Target to $620.00